Search

Dámaso Molero, CEO of 3P Biopharmaceuticals, Silver Sponsor of BIOSPAIN 2023, analyzes the snapshot we observe of the 'biotech' sector and the company's plans for the future.

New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing a novel proprietary platform for cytokine-based therapies targeting autoimmune and inflammatory

VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international projects in compliance with FDA

Meet Globalfinanz, our new ally. We talked to Begoña Torregrosa, partner and head of Collectives.

In recent years, Spain has achieved significant progress that has improved its ability to attract innovative talent, although many barriers still persist. We analyze the situation with LIM Global

From AseBio, we have analyzed the program of the Spanish Presidency and where R&D and biotechnology would be present, with the mission of identifying points on which we can have an impact and work

The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st conference on the cellular secretome to highlight the potential of this pathway

Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients.

Meet Binit Tech, our new ally. We talked to Leandro Harillo, Technology Director.

Meet Zeta GmbH, our new member. We talked to Andreas Marchler, CEO of the company and with Christine Kolland, Business Development in Spain.

Meet Bexen Medical, our new member. We talked to Manuel Sánchez-Lagarejo, CEO of the company.

Meet r Multipartner Virtual Data Room, our new member. We talked to María del Mar García, Area Manager Spain & LatAm at the company